LIS Technologies Inc., the Only U.S.-Origin and Patented Technology for Laser Uranium Enrichment Announces Elite Level Sponsorship of the 2025 American Nuclear Society Winter Conference & Expo
Oak Ridge, Tennessee, Nov. 11, 2025 (GLOBE NEWSWIRE) -- LIS Technologies Inc.…
OSS to Demonstrate Best-In-Class High Performance Compute Portfolio at SC25
Company to showcase portfolio of ultra-dense, high-performance computing performance solutions for commercial…
Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock
November 10, 2025 21:56 ET Â | Source: Vor Biopharma BOSTON, Nov. 10,…
Air Serbia and Loyalty Juggernaut Partner to Launch a Next-Generation Frequent Flyer Program
Partnership marks a milestone in Air Serbia's centenary journey, uniting tradition, innovation,…
RUNSTACK Unveils Hypergraph Long-Term Memory for Agentic Systems
NORTH YORK, Ontario, Nov. 10, 2025 (GLOBE NEWSWIRE) -- RUNSTACK Inc., a…
Marriott International Announces Termination of Agreement with Sonder
BETHESDA, Md., Nov. 9, 2025 /PRNewswire/ -- Marriott International, Inc. (NASDAQ: MAR)…
Cango Inc. Releases Letter to Shareholders
HONG KONG, Nov. 6, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) today…
Cango Inc. Announces October 2025 Bitcoin Production and Mining Operations Update
HONG KONG, Nov. 3, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango"…
Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema
November 08, 2025 17:13 ET Â | Source: Intellia Therapeutics, Inc. Deep, stable…
Clinical Data Demonstrating Efficacy of Sotagliflozin in Preserved Ejection Fraction Heart Failure (HFpEF) without Diabetes Presented at American Heart Association (AHA) Annual Scientific Sessions 2025
THE WOODLANDS, Texas, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc.…